Dr. Poornima Bhatt

About

Dr. Poornima Bhatt is an Assistant Professor at the University Centre for Research and Development, Chandigarh University, Mohali, Punjab. Her research focuses on the development of advanced biosensors, nanomaterials, and point-of-care diagnostic platforms for the early detection and monitoring of chronic diseases, particularly chronic kidney disease (CKD). Her work integrates nanotechnology, electrochemical sensing, fluorescence-based sensing, and bioanalytical techniques for the detection of clinically relevant biomarkers.

Dr. Bhatt has contributed to the design and development of innovative sensing platforms based on carbon dots, graphene derivatives, MXenes, metal-organic frameworks, and antibody-assisted detection systems. Her research has resulted in publications in reputed international journals and has been recognized through prestigious research fellowships and grants. Her current interests include electrochemical and optical biosensors, nanobiotechnology, biomarker discovery, point-of-care diagnostics, wearable sensing technologies, and artificial intelligence-assisted healthcare diagnostics.

She is committed to advancing translational research that bridges fundamental science and practical healthcare applications, with the aim of improving early disease diagnosis and patient outcomes.

Keywords: Biosensors, Nanotechnology, Electrochemical Sensors, Fluorescence Sensing, Carbon Dots, MXenes, Aptamers, Chronic Kidney Disease, Biomarkers, Point-of-Care Diagnostics, Nanobiotechnology, Healthcare Diagnostics.

Employment

• Chandigarh University Assistant Professor
  2026 - Present
• Chandigarh University Women Scientist (DST-WISE-PhD)
  2022 - 2025
• Ram devi Jindal group of institutions Assistant professor
  2021 - 2022

Education

• Kumaun University Master of Science
  2012 - 2014
• Kumaun University Bachelor of Science in Biotechnology
  2009 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (19)

• Comprehensive review of chronic kidney disease molecular biomarkers: Clinical significance, human health impact, and emerging diagnostic strategies
  Clinica Chimica Acta 2027 DOI: 10.1016/j.cca.2026.121278
  +Save
• SPCE/rGO/AuNPs-based robust electrochemical sensor for creatinine detection in human serum
  Surfaces and Interfaces 2026 DOI: 10.1016/j.surfin.2026.110328
  +Save
• Next-generation biosensing platforms: critical analysis of nanomaterial-enabled strategies and clinical translation
  Biosensors and Biomolecular Electronics 2026 DOI: 10.1186/s44510-026-00002-7
  +Save
• Electrochemical nanosensors using MXene-carbon dot modified screen-printed carbon electrodes for creatinine detection in serum samples
  Materials Advances 2026 DOI: 10.1039/d5ma00539f
  +Save
• Nanomaterials-mediated electrochemical detection of neutrophil gelatinase-associated lipocalin for chronic kidney disease: Advances, challenges, and future prospects
  Talanta 2026 DOI: 10.1016/J.TALANTA.2025.128473
  +Save
• The expanding horizon of aptamer-modified metal-organic framework for the biosensing of chronic kidney disease biomarkers
  Microchemical Journal 2026 DOI: 10.1016/J.MICROC.2026.118121
  +Save
• Glutathione capped gold nanoparticles-based fluorescent biosensor for dual detection of albumin and creatinine
  Microchemical Journal 2025 DOI: 10.1016/J.MICROC.2024.112457
  +Save
• Recent advancements in patented technologies for the diagnosis and treatment of chronic kidney disease
  International Urology and Nephrology 2025 DOI: 10.1007/S11255-025-04501-6
  +Save
• Novel nanomaterials-based combating strategies against drug-resistant bacteria
  Colloids and Surfaces B: Biointerfaces 2025 DOI: 10.1016/J.COLSURFB.2024.114478
  +Save
• Metagenomic profiling of gut microbime: associating their role with the advancement of diabetic nephropathy
  Antonie van Leeuwenhoek 2025 DOI: 10.1007/S10482-025-02141-5
  +Save